Literature DB >> 7929628

Receptor-mediated endocytosis is sensitive to antibodies against the uncoating ATPase (hsc70).

S Höning1, G Kreimer, H Robenek, B M Jockusch.   

Abstract

We have investigated the functional role of the coated vesicle-uncoating ATPase (UA), a cognate heat shock protein (hsc70), in receptor-mediated endocytosis. A monoclonal antibody against bovine brain UA/hsc70 was generated that recognizes a 26 kDa proteolytic fragment harbouring the putative clathrin-binding site. In vitro, this antibody blocked the UA/hsc70-mediated release of clathrin from isolated coated vesicles (CVs). Upon microinjection into tissue culture cells, it specifically inhibited the heat shock-induced nuclear migration of UA/hsc70. This antibody also interfered with endocytosis of ligand-receptor complexes in injected cells. Two different systems were studied: the uptake of aggregated human IgG by BHK cells transfected with a human Fc receptor (FcRII), and the internalization of LDL by human fibroblasts. Injection of the monoclonal antibody in concentrations yielding approximately equal molar ratios of antibody to enzyme resulted in a reduction of endocytosis to 20-30% of control values, as seen by conventional light and confocal laser scanning microscopy, and by electron microscopy. In the transfected BHK cells, the endocytosed ligand remained associated with the labeling for clathrin and was not delivered to the endosomal compartment within the period expected from control serum- or non-injected cells. Thin sections revealed an accumulation of coated structures in the antibody-injected cells as compared to controls. Thus, our data show that UA is essential for normal receptor-mediated endocytosis, and is presumably involved in the uncoating of CVs preceding their fusion with endosomes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929628     DOI: 10.1242/jcs.107.5.1185

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  9 in total

1.  Hsc/Hsp70 interacting protein (hip) associates with CXCR2 and regulates the receptor signaling and trafficking.

Authors:  Guo-Huang Fan; Wei Yang; Jiqing Sai; Ann Richmond
Journal:  J Biol Chem       Date:  2001-12-19       Impact factor: 5.157

2.  Identification of genes that interact with Drosophila liquid facets.

Authors:  Suk Ho Eun; Kristi Lea; Erin Overstreet; Samuel Stevens; Ji-Hoon Lee; Janice A Fischer
Journal:  Genetics       Date:  2006-12-18       Impact factor: 4.562

3.  The tyrosine-based lysosomal targeting signal in lamp-1 mediates sorting into Golgi-derived clathrin-coated vesicles.

Authors:  S Höning; J Griffith; H J Geuze; W Hunziker
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

4.  Inhibition of hsc70-catalysed clathrin uncoating by HSJ1 proteins.

Authors:  M E Cheetham; B H Anderton; A P Jackson
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

5.  Hepatitis B virus large envelope protein interacts with gamma2-adaptin, a clathrin adaptor-related protein.

Authors:  C Hartmann-Stühler; R Prange
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

6.  ATP- and cytosol-dependent release of adaptor proteins from clathrin-coated vesicles: A dual role for Hsc70.

Authors:  L A Hannan; S L Newmyer; S L Schmid
Journal:  Mol Biol Cell       Date:  1998-08       Impact factor: 4.138

7.  Hsc70 is required for endocytosis and clathrin function in Drosophila.

Authors:  Henry C Chang; Sherri L Newmyer; Michael J Hull; Melanie Ebersold; Sandra L Schmid; Ira Mellman
Journal:  J Cell Biol       Date:  2002-11-11       Impact factor: 10.539

8.  Dominant-interfering Hsc70 mutants disrupt multiple stages of the clathrin-coated vesicle cycle in vivo.

Authors:  S L Newmyer; S L Schmid
Journal:  J Cell Biol       Date:  2001-02-05       Impact factor: 10.539

9.  The J-domain protein Rme-8 interacts with Hsc70 to control clathrin-dependent endocytosis in Drosophila.

Authors:  Henry C Chang; Michael Hull; Ira Mellman
Journal:  J Cell Biol       Date:  2004-03-29       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.